Bradley-Whitman, M., Roberts, K., Abner, E., Scheff, S., Lynn, B., & Lovell, M. A novel method for the rapid detection of post-translationally modified visinin-like protein 1 in rat models of brain injury. Brain Injury, 32(3), 363-380. https://doi.org/10.1080/02699052.2017.1418907 (Original work published 2018)

Bradley-Whitman, M., Abner, E., Lynn, B., & Lovell, M. A Novel Plasma Based Biomarker of Alzheimer’s Disease. Journal of Alzheimer’s Disease : JAD, 47(3), 761-71. https://doi.org/10.3233/JAD-150183 (Original work published 2015)

Bradley-Whitman, M., Timmons, M., Beckett, T., Murphy, M., Lynn, B., & Lovell, M. (2014). Nucleic acid oxidation: an early feature of Alzheimer’s disease. Journal of Neurochemistry, 128(2), 294-304. https://doi.org/10.1111/jnc.12444

Ellison, E., Bradley-Whitman, M., & Lovell, M. (2017). Single-Base Resolution Mapping of 5-Hydroxymethylcytosine Modifications in Hippocampus of Alzheimer’s Disease Subjects. Journal of Molecular Neuroscience : MN, 63(2), 185-197. https://doi.org/10.1007/s12031-017-0969-y

Bradley-Whitman, M., & Lovell, M. (2015). Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update. Archives of Toxicology, 89(7), 1035-44. https://doi.org/10.1007/s00204-015-1517-6

Bradley-Whitman, M., & Lovell, M. (2013). Epigenetic changes in the progression of Alzheimer’s disease. Mechanisms of Ageing and Development, 134(10), 486-95. https://doi.org/10.1016/j.mad.2013.08.005